Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology Department, Hospital | 2 | 2020 | 25 | 1.270 |
Why?
|
| Foreign Bodies | 2 | 2021 | 96 | 1.260 |
Why?
|
| Ileal Diseases | 3 | 2024 | 26 | 0.960 |
Why?
|
| Intussusception | 2 | 2024 | 54 | 0.880 |
Why?
|
| Nuclear Medicine | 3 | 2025 | 7 | 0.870 |
Why?
|
| Multimodal Imaging | 5 | 2020 | 110 | 0.870 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2025 | 37 | 0.860 |
Why?
|
| Radiopharmaceuticals | 10 | 2025 | 160 | 0.820 |
Why?
|
| Intestinal Volvulus | 2 | 2021 | 41 | 0.810 |
Why?
|
| Digestive System Abnormalities | 2 | 2021 | 38 | 0.810 |
Why?
|
| Diagnostic Imaging | 1 | 2025 | 304 | 0.740 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2023 | 2060 | 0.720 |
Why?
|
| Hospitals, Pediatric | 5 | 2025 | 797 | 0.670 |
Why?
|
| Referral and Consultation | 1 | 2025 | 551 | 0.670 |
Why?
|
| Teleradiology | 1 | 2020 | 6 | 0.650 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2022 | 125 | 0.640 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 9 | 0.640 |
Why?
|
| Pandemics | 5 | 2022 | 1157 | 0.630 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 27 | 0.630 |
Why?
|
| Hospitals, Community | 1 | 2020 | 51 | 0.620 |
Why?
|
| Child Health Services | 1 | 2020 | 86 | 0.590 |
Why?
|
| KATP Channels | 1 | 2018 | 11 | 0.570 |
Why?
|
| Glucagon | 2 | 2018 | 146 | 0.560 |
Why?
|
| Somatostatin | 1 | 2018 | 60 | 0.560 |
Why?
|
| Potassium Channel Blockers | 1 | 2018 | 84 | 0.550 |
Why?
|
| Ultrasonography | 6 | 2024 | 948 | 0.520 |
Why?
|
| Pancreas | 2 | 2018 | 219 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 282 | 0.510 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 351 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 363 | 0.450 |
Why?
|
| Child | 26 | 2025 | 26098 | 0.440 |
Why?
|
| Pediatrics | 2 | 2025 | 1240 | 0.430 |
Why?
|
| Glucose | 2 | 2018 | 852 | 0.420 |
Why?
|
| Positron-Emission Tomography | 6 | 2022 | 288 | 0.420 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 79 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 774 | 0.410 |
Why?
|
| Enema | 2 | 2024 | 44 | 0.390 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 86 | 0.380 |
Why?
|
| Organometallic Compounds | 2 | 2021 | 110 | 0.320 |
Why?
|
| Workflow | 2 | 2021 | 142 | 0.310 |
Why?
|
| Neuroendocrine Tumors | 2 | 2021 | 68 | 0.310 |
Why?
|
| Epilepsy | 1 | 2017 | 863 | 0.300 |
Why?
|
| Humans | 38 | 2025 | 130441 | 0.300 |
Why?
|
| Esophagus | 2 | 2021 | 232 | 0.300 |
Why?
|
| Receptors, Drug | 4 | 2002 | 27 | 0.300 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 4 | 2002 | 36 | 0.300 |
Why?
|
| Infant | 9 | 2024 | 13228 | 0.290 |
Why?
|
| Potassium Channels | 4 | 2002 | 153 | 0.280 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2002 | 192 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 3749 | 0.250 |
Why?
|
| Societies, Medical | 2 | 2021 | 792 | 0.240 |
Why?
|
| Child, Preschool | 8 | 2024 | 14944 | 0.220 |
Why?
|
| Islets of Langerhans | 3 | 2018 | 160 | 0.210 |
Why?
|
| Neuroblastoma | 2 | 2020 | 543 | 0.210 |
Why?
|
| Appendicitis | 2 | 2024 | 132 | 0.210 |
Why?
|
| Retrospective Studies | 8 | 2024 | 17514 | 0.200 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 22 | 0.200 |
Why?
|
| Artificial Intelligence | 3 | 2023 | 351 | 0.200 |
Why?
|
| Academic Medical Centers | 1 | 2025 | 320 | 0.190 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 1547 | 0.190 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 29 | 0.190 |
Why?
|
| Consensus | 1 | 2025 | 517 | 0.190 |
Why?
|
| Radiography | 2 | 2021 | 740 | 0.180 |
Why?
|
| Arylsulfotransferase | 1 | 2021 | 5 | 0.180 |
Why?
|
| Rectal Prolapse | 1 | 2021 | 6 | 0.180 |
Why?
|
| Insulin | 3 | 2002 | 1140 | 0.180 |
Why?
|
| Adolescent | 11 | 2023 | 20727 | 0.170 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2021 | 44 | 0.170 |
Why?
|
| Myofibroma | 1 | 2021 | 9 | 0.170 |
Why?
|
| Bronchi | 1 | 2021 | 98 | 0.170 |
Why?
|
| Colectomy | 1 | 2021 | 89 | 0.170 |
Why?
|
| Neuroimaging | 2 | 2021 | 382 | 0.160 |
Why?
|
| Organizational Objectives | 1 | 2020 | 35 | 0.160 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.160 |
Why?
|
| Octreotide | 1 | 2020 | 24 | 0.160 |
Why?
|
| Radiology | 1 | 2022 | 119 | 0.160 |
Why?
|
| Contrast Media | 2 | 2021 | 474 | 0.160 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.160 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 52 | 0.160 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 111 | 0.160 |
Why?
|
| Workplace | 1 | 2020 | 81 | 0.150 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2019 | 22 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 206 | 0.140 |
Why?
|
| Crohn Disease | 1 | 2021 | 290 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2021 | 298 | 0.140 |
Why?
|
| Histiocytosis | 1 | 2017 | 18 | 0.130 |
Why?
|
| Glioma | 1 | 2022 | 507 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 763 | 0.120 |
Why?
|
| Mice, Knockout | 4 | 2018 | 3830 | 0.120 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 28 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 4035 | 0.110 |
Why?
|
| Models, Biological | 1 | 2000 | 1383 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2021 | 6424 | 0.110 |
Why?
|
| Male | 12 | 2024 | 64473 | 0.100 |
Why?
|
| Nausea | 1 | 2014 | 83 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 695 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1287 | 0.100 |
Why?
|
| Gastric Emptying | 1 | 2014 | 78 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 471 | 0.100 |
Why?
|
| Gastroparesis | 1 | 2014 | 69 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 2088 | 0.100 |
Why?
|
| Lymphoma | 1 | 2016 | 328 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12835 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2014 | 315 | 0.090 |
Why?
|
| Texas | 1 | 2020 | 3643 | 0.090 |
Why?
|
| Receptors, Somatostatin | 2 | 2020 | 55 | 0.080 |
Why?
|
| Sulfonylurea Receptors | 4 | 2002 | 12 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2014 | 538 | 0.070 |
Why?
|
| Radionuclide Imaging | 2 | 2021 | 114 | 0.070 |
Why?
|
| Tertiary Care Centers | 2 | 2021 | 249 | 0.070 |
Why?
|
| Mice | 5 | 2018 | 18229 | 0.060 |
Why?
|
| Female | 9 | 2024 | 70354 | 0.060 |
Why?
|
| Young Adult | 2 | 2017 | 9993 | 0.060 |
Why?
|
| North America | 1 | 2025 | 256 | 0.050 |
Why?
|
| United States | 1 | 2020 | 11874 | 0.050 |
Why?
|
| Animals | 6 | 2018 | 33857 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2023 | 132 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 52 | 0.050 |
Why?
|
| Carbazoles | 1 | 2002 | 30 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2896 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 158 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2002 | 228 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2002 | 81 | 0.040 |
Why?
|
| Radiologists | 1 | 2022 | 52 | 0.040 |
Why?
|
| Radioisotopes | 1 | 2021 | 26 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 54 | 0.040 |
Why?
|
| Cryptorchidism | 1 | 2021 | 37 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2021 | 309 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 418 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2002 | 296 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2000 | 50 | 0.040 |
Why?
|
| Sulfonylurea Compounds | 1 | 2000 | 21 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 232 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 3030 | 0.040 |
Why?
|
| Colitis | 1 | 2021 | 166 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 364 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2000 | 80 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 587 | 0.040 |
Why?
|
| Documentation | 1 | 2021 | 121 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 561 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2021 | 240 | 0.040 |
Why?
|
| Eye | 1 | 2021 | 220 | 0.040 |
Why?
|
| Reference Values | 2 | 2015 | 675 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 169 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2000 | 251 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2000 | 293 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 437 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 701 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 2000 | 183 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1875 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 591 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2002 | 1109 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2000 | 217 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2019 | 317 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2019 | 306 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1216 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1244 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1107 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6201 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1994 | 32 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 1948 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8520 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 300 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1219 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2826 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 31121 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 692 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5153 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2002 | 687 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2002 | 325 | 0.020 |
Why?
|
| Base Sequence | 2 | 2002 | 2734 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 3469 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2002 | 43 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 2002 | 39 | 0.010 |
Why?
|
| Insulinoma | 1 | 2002 | 8 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2002 | 112 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2002 | 77 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 413 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 152 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2002 | 198 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 576 | 0.010 |
Why?
|
| Indoles | 1 | 2002 | 199 | 0.010 |
Why?
|
| Pyrroles | 1 | 2002 | 189 | 0.010 |
Why?
|
| Perfusion | 1 | 2002 | 209 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 691 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 976 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 451 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 960 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 559 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 1206 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 1136 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 723 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1456 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1595 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1210 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 1486 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1610 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 3371 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2002 | 736 | 0.010 |
Why?
|
| Half-Life | 1 | 1994 | 148 | 0.010 |
Why?
|
| Cricetinae | 1 | 1994 | 361 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 2397 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 2557 | 0.000 |
Why?
|